Antiproliferative Activity of Cisplatin Detected by CFSE in p53-Proficient and p53-Deficient Cells
- 1 January 2007
- journal article
- research article
- Published by Taylor & Francis Ltd in Immunological Investigations
- Vol. 36 (5-6), 847-859
- https://doi.org/10.1080/08820130701674836
Abstract
We have previously developed experimental and data analysis procedures to measure the antiproliferative activity of drugs in continuously proliferating cancer cell lines using carboxyfluorescein diacetate succinimidyl ester (CFSE). The method was applied here to analyze the role of p53 in the effect of the anticancer drug cisplatin, distinguishing events occurring in the first generation of cells from those in the second and subsequent generations. A CFSE-loaded colon carcinoma cell line expressing functional wild-type p53 was treated for 1 with cisplatin in parallel with its p53-deficient counterpart, collecting frequency distributions of DNA and CFSE content up to 72 h after treatment. At a sublethal cisplatin concentration proliferation was temporarily inhibited but then the block was overcome and most cells were able to divide several times. The initial block was stronger in HCTp53-/- cells, resulting in a larger proportion of undivided cells at 24 h. This was confirmed and amplified at a higher, lethal concentration, where undivided G2M-blocked p53-deficient cells eventually died by non-apoptotic mechanisms, while p53-proficient cells avoided this with a less stringent block. This gave p53-proficient cells more time to repair and eventually decide on survival or apoptotic death before traversing the cycle into their second generation.Keywords
This publication has 16 references indexed in Scilit:
- The Contribution of p53 in the Dynamics of Cell Cycle Response to DNA Damage Interpreted by a Mathematical ModelCell Cycle, 2007
- p53 and p21 Determine the Sensitivity of Noscapine-Induced Apoptosis in Colon Cancer CellsCancer Research, 2007
- Heterogeneous cell response to topotecan in a CFSE‐based proliferation testCytometry Part A, 2004
- Activation of the p53-dependent G1 checkpoint response in mouse embryo fibroblasts depends on the specific DNA damage inducerOncogene, 2004
- Surfing the p53 networkNature, 2000
- Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G 1 arrest after γ-irradiationProceedings of the National Academy of Sciences of the United States of America, 1999
- Regulation ofp53downstream genesSeminars in Cancer Biology, 1998
- Requirement for p53 and p21 to Sustain G 2 Arrest After DNA DamageScience, 1998
- Determination of lymphocyte division by flow cytometryJournal of Immunological Methods, 1994
- p53 Mutations in Human CancersScience, 1991